Trial Profile
Lacosamid-i.v.-Register
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2020
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- 27 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Jun 2012 New trial record